Lewis B. Morgenstern, MD

Articles by Lewis B. Morgenstern, MD

Targeting High-Risk Employees May Reduce Cardiovascular Racial Disparities

ByJames F. Burke, MD, MS,Sandeep Vijan, MD,Lynette A. Chekan, MBA,Ted M. Makowiec, MBA,Laurita Thomas, MEd,Lewis B. Morgenstern, MD

September 17th 2014

Targeting cardiovascular risk reduction interventions to high-risk patients has the potential to reduce cardiovascular racial disparities, improve health, and reduce costs.

Latest Updated Articles

Targeting High-Risk Employees May Reduce Cardiovascular Racial Disparities
Published: September 17th 2014 | Updated:

Lewis B. Morgenstern, MD

Articles by Lewis B. Morgenstern, MD

Targeting High-Risk Employees May Reduce Cardiovascular Racial Disparities

Latest Updated Articles

Trending on AJMC

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD